Reviewer #2 (Remarks to the Author)
The manuscript describes basic rules of applying dCas9-HDAC3 for directing targeted changes to the histone modifications and consequent gene regulation. Many of the analyses are clear and to the point, especially the last two figures (3&4). Statistical analyses seem reasonable. Design principles presented in the manuscript will be very useful for targeted epigenetic modifications using HDAC3. In addition, the context dependent effect of HDAC3 was very interesting observation, especially in figure 4. The study does not go far enough to resolve the predictability of the HDAC3 action; this may be a missed opportunity. Nonetheless, the authors presents nice set of data that will be valuable in designing targeted epigenetic modifiers.
One minor criticism of the paper is the relatively weak effects presented in figure 2. The magnitude of the effect is very small, when compared to the previously published work (or even to the results presented in figure 4 ). This is likely due to the transient plasmid transfection approach used in these studies, even though the vectors are suitable for viral packaging and transduction for a more potent delivery (as seen in other reports). We thank this reviewer for his/her appreciation of our study and for recognizing the value of our findings. We also appreciate their suggestion of multiplexing gRNAs to examine whether their simultaneous expression might synergistically improve dCas9-HDAC3's effect on gene transcription as has been observed with CRISPR-based activators. To address this, we co-expressed 2-3 gRNAs used in this study with either dCas9-HDAC3 or dCas9-HDAC3-R265P for each respective locus. To avoid the confounding effect of steric inhibition of transcription (as was observed when dCas9-HDAC3 or -R265P was positioned downstream of the TSS) we only chose to multiplex those gRNAs complementary to regions upstream of the TSS (Fig. 1 ).
Response to referees:
For each locus tested (Smn, Mecp2, and Isl1), co-transfection of 2 to 3 gRNAs in N2a cells did not result in any observable effects on transcription (Fig. 1) . In fact, any dCas9-HDAC3-mediated effect that we observed with single expression of gRNA (Smn gRNA-3 on Smn; Mecp2 gRNA-3 on Mecp2) was abrogated when co-expressed with another gRNA. This may be due to the diverting of dCas9-HDAC3 from its optimal deacetylation position to other gRNA locations, or impedance of its activity when dCas9-HDAC3 is also bound elsewhere in the promoter, thus reducing its effect on gene expression. However, as most our gRNAs were designed to bind to positions approximately one nucleosome or more apart, we cannot rule out the possibility that synergistic effects may be seen with the co-expression of multiple gRNAs tiled closely around a promoter locus with dCas9-HDAC3. This figure has been added to our manuscript ( Supplementary Fig. 1 ) and described on page 6, lines 20 to page 7, line 2 (highlighted).
We also thank the reviewer for advising us to include and discuss examples of epigenomic editing utilizing other epigenome remodelers NCoR, HDACs, etc.) . We have now included those references in our manuscript on page 9, line 9-24 (highlighted).
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